Literature DB >> 6202155

Cholecystokinin receptor antagonists.

J D Gardner, R T Jensen.   

Abstract

Since 1979 three classes of cholecystokinin receptor antagonists have been described: 1) derivatives of cyclic nucleotides, 2) derivatives of amino acids, and 3) C-terminal fragments or partial sequences of cholecystokinin. These various antagonists share a number of common features, such as their specific, reversible, and competitive actions, but they vary in the potency with which they inhibit the actions of cholecystokinin.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6202155     DOI: 10.1152/ajpgi.1984.246.5.G471

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  6 in total

1.  Calcium oscillations in guinea-pig pancreatic acinar cells exposed to carbachol, cholecystokinin and substance P.

Authors:  L Sjödin; H G Dahlén; E Gylfe
Journal:  J Physiol       Date:  1991-12       Impact factor: 5.182

2.  Design of potent, orally effective, nonpeptidal antagonists of the peptide hormone cholecystokinin.

Authors:  B E Evans; M G Bock; K E Rittle; R M DiPardo; W L Whitter; D F Veber; P S Anderson; R M Freidinger
Journal:  Proc Natl Acad Sci U S A       Date:  1986-07       Impact factor: 11.205

3.  Effect of a new cholinergic agonist, aclatonium napadisilate, on exocrine and endocrine rat pancreas.

Authors:  M Otsuki; T Nakamura; Y Okabayashi; M Fujii; S Tani; T Fujisawa; S Baba
Journal:  Dig Dis Sci       Date:  1989-08       Impact factor: 3.199

Review 4.  Perspectives of CCK antagonists in pancreatic research. Part II. Experimental studies.

Authors:  T Takács; A Pap
Journal:  Int J Pancreatol       Date:  1991-09

5.  Pathogenesis of the impaired gall bladder contraction of coeliac disease.

Authors:  A M Brown; M J Bradshaw; R Richardson; J G Wheeler; R F Harvey
Journal:  Gut       Date:  1987-11       Impact factor: 23.059

6.  Effect of intravenous infusion of proglumide on ruminal motility in conscious sheep (Ovis aries).

Authors:  T Onaga
Journal:  Vet Res Commun       Date:  2007-02-05       Impact factor: 2.816

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.